Results 201 to 210 of about 1,229,322 (315)

Visible-infrared person re-identification with region-based augmentation and cross modality attention. [PDF]

Sci Rep
Guo Y, Zhang W, Jiao L, Wang S, Wang S, Liu F.   +5 more
europepmc   +1 more source

Person Re-Identification with Improved Performance by Incorporating Focal Tversky Loss in AGW Baseline. [PDF]

Sensors (Basel), 2022
Huang SK, Hsu CC, Wang WY.
europepmc   +1 more source

Endoglin mediates the tumor‐ and metastasis‐promoting traits of stromal myofibroblasts in human breast carcinomas

Molecular Oncology, EarlyView.
Carcinoma‐associated fibroblasts (CAFs) in tumors influence cancer progression. We identified endoglin (ENG) as a key factor in TGF‐β signaling in myofibroblastic CAFs (myCAFs), linked to poor breast cancer outcomes. Inhibiting ENG on myCAFs suppressed the TGF‐β‐Smad2/3 pathway, reducing primary tumor growth and metastasis.
Shoki Okubo, Yoshihiro Mezawa, Zixu Wang, Ahmet Acar, Yasuhiko Ito, Atsushi Takano, Yohei Miyagi, Tomoyuki Yokose, Toshinari Yamashita, Yataro Daigo, Takuya Shirakihara, Akira Orimo   +11 more
wiley   +1 more source

An Investigation of the Domain Gap in CLIP-Based Person Re-Identification. [PDF]

Sensors (Basel)
Asperti A, Naldi L, Fiorilla S.
europepmc   +1 more source

Association of high‐dose radioactive iodine therapy with PPM1D‐mutated clonal hematopoiesis in older individuals

Molecular Oncology, EarlyView.
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim, Sungwoo Bae, Jaeyong Choi, Sun‐Wha Im, Bukyoung Cha, Gyeongseo Jung, Sun Wook Cho, Eul‐Ju Seo, Young Ah Lee, Jin Chul Paeng, Young Joo Park, Jong‐Il Kim   +11 more
wiley   +1 more source

BiFFN: Bi-Frequency Guided Feature Fusion Network for Visible-Infrared Person Re-Identification. [PDF]

Sensors (Basel)
Cao X, Ding P, Li J, Chen M.
europepmc   +1 more source

Deep Metric Learning for Scalable Gait-Based Person Re-Identification Using Force Platform Data. [PDF]

Sensors (Basel), 2023
Duncanson KA, Thwaites S, Booth D, Hanly G, Robertson WSP, Abbasnejad E, Thewlis D.   +6 more
europepmc   +1 more source

Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management

Molecular Oncology, EarlyView.
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez, Asieh Naderi, Kim‐Tuyen Huynh‐Dam, Vitali Sikirzhytski, Ioulia Chatzistamou, Hippokratis Kiaris   +5 more
wiley   +1 more source

Unleashing the Potential of Pre-Trained Diffusion Models for Generalizable Person Re-Identification. [PDF]

Sensors (Basel)
Li J, Gong X.
europepmc   +1 more source

Heterogeneous feature-aware Transformer-CNN coupling network for person re-identification. [PDF]

PeerJ Comput Sci, 2022
Li Y, Lian G, Zhang W, Ma G, Ren J, Yang J.   +5 more
europepmc   +1 more source